ATEMANALYSATOR

European patent · EP4025125 · In force

Register entry

Publication number
EP4025125
Application number
EP20750816
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jun 9, 2020
Published
Jul 13, 2022
Granted
Aug 6, 2025
Protection ends at the latest
Jun 8, 2040
Next annual fee due
Jun 30, 2027
IPC classes
A61B 5/097 (2006.01)
A61B 5/08 (2006.01)
A61B 5/00 (2006.01)
Priority
US 201962879345 P 26.07.2019
WO PCT/US2019/065550 10.12.2019
PCT application
PCT/US2020/036793 09.06.2020
PCT publication
WO2021/021299 04.02.2021
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. Jun 17, 2026

    Change

    Published in Swissreg on 17.06.2026

  3. Aug 6, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 06.08.2025

Parties

Holder

Heteron Biotechnologies, LLC

18 Blueberry Ridge Road, Setauket, New York 11733, US

Rigas, Anastasia

Setauket, New York 11733, US

Inventor

CHIANG, Hao-Chun

New York 11791, US

LEVON, Kalle

Brooklyn, New York 11238, US

ARTAN, Nabi Sertac

Brooklyn, New York 11223, US

AMOAKO, Edward

New York 11368, US

RIGAS, Anastasia

New York 11733, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.